ABSTRACT Central stimulant actions of 10 methylxanthines in mice correlate with affinities for adenosine receptors labeled with N6-[3H]cyclohexyladenosine. Affinities of methylxanthines for adenosine receptors are consonant with central levels attained at behaviorally effective doses. The much higher concentrations ofmethylxanthines required to influence benzodiazepine receptor binding do not correlate with behavioral potency. N6-(L-Phenylisopropyl)adenosine (L-PIA), a metabolically stable analog ofadenosine with high affinity for adenosine receptors, is an extremely potent behavioral depressant, reducing locomotor activity of mice at doses as little as 0.05 ,.mol/kg. The D isomer, which has much less affinity for adenosine receptors, is much less active as a central depressant. Theophylline stimulates locomotor activity and reverses depressant effects of L-PIA. Caffeine or 1,7-dimethylxanthine, when administered alone, elicits biphasic effects, with locomotor depression at lower doses and stimulation at higher doses. When administered with L-PIA, even low doses of caffeine produce marked stimulation. 3-Isobutyl-1-methylxanthine given alone elicits only behavioral depression. However, like theophylline and caffeine, isobutylmethylxanthine reverses the L-PIA-evoked depression, converting it into pronounced locomotor stimulation. The data strongly suggest that the behavioral stimulant effects of methylxanthines involve a blockade of central adenosine receptors. Although methylxanthines such as caffeine and theophylline are among the most widely used behavioral stimulant substances, molecular mechanisms for their stimulant effects are unclear. Methylxanthines can inhibit phosphodiesterase, and thus prevent inactivation of cyclic AMP (1), but the concentrations of caffeine and theophylline required to inhibit phosphodiesterases are substantially greater than those which occur in brain at behaviorally effective doses (2, 3). Moreover, several potent phosphodiesterase inhibitors lack behavioral stimulant actions and indeed are central depressants (4). Adenosine receptor activity is blocked by methylxanthines in concentrations similar to those that occur after stimulant doses (5, 6). Because the general neurophysiologic actions of adenosine are inhibitory (7), it is conceivable that methylxanthines exert stimulant actions by blocking adenosine effects.
In several attempts to measure binding of adenosine-related ligands to membranes, binding sites largely lacked the specificity of physiologic adenosine receptors (8) (9) (10) (11) (12) . Recently, we (13, 14) and others (15, 16) have demonstrated binding of 3H-labeled ligands to adenosine receptors in brain and testes (15, 17) .
In the present study we show a correlation between potencies of a series of methylxanthines in stimulating locomotor activity of mice and in competing at adenosine receptors labeled with
N6-[3H]cyclohexyladenosine ([3H]CHA)
. Both CHA and N6-(Lphenylisopropyl)adenosine (L-PIA), stable and potent adenosine analogs, are shown to be extremely potent behavioral depressants. Low doses of xanthines dramatically reverse the L-PIA-evoked depression.
MATERIALS AND METHODS Biochemical.
[3H]CHA binding to whole mouse brain membranes was assayed as reported (13) . Properties of [3H]CHA binding to mouse brain membrane were essentially the same as for guinea pig brain (13) .
[3H]Flunitrazepam binding to mouse brain membranes was assayed as before (18) .
[3H]CHA (14 Ci/mmol; 1 Ci = 3.7 x 101 becquerels) and
[3H]flunitrazepam (79 Ci/mmol) were obtained from New England Nuclear. The sources ofxanthines were as described (13) .
Behavioral. Naive adult male ICR mice (2540 g) from Blue Spruce Farms (Altamont, NY) were given food and water ad lib. The mice were housed 20 per cage in 26 X 46 X 17 cm polypropylene cages and were exposed to a 12-hr/12-hr light/dark cycle (lights on, 0700). Mice were permitted to adapt to their housing for a minimum of48 hr before testing. Behavioral tests were performed between 0800 and 1800. For each shipment of mice, received every 4 weeks, new control groups were established. Unless stated otherwise, all drugs were administered as a saline solution given intraperitoneally at 10 t.d/g of body weight.
Mice received drugs 10 min prior to the 1-hr locomotor activity testing period and were placed individually in holding cages containing a sawdust bedding similar to that oftheir group cages.
Locomotor activity data were subjected to parametric statistical analysis by using repeated measures three-way analysis of variance and covariance with the least-squares computation for unequal numbers. Two independent subjects grouping factors consisted of the drugs and the various doses in which they were administered. The repeated measures of spontaneous locomotor activity during a testing session were considered the withinsubject dependent repeated measure. This analysis of variance was repeated with a logarithmic transformation of the data. Student's t test was used for making individual comparisons.
Locomotor activity was measured in four identical automated 38 X 38 X 38 cm open-field devices built, in our laboratories, of black Plexiglas. The ceiling of white Plexiglis concealed a 6-W fluorescent light fixture to provide background illumination and an exhaust fan for ventilation. Sixty-four cadmium sulfide photosensitive devices were placed under the transparent Plexiglas floor 3.8 cm apart in an 8 x 8 array and connected to an Intel microcomputer that monitored the state and location of the photosensitive elements 10 times per sec. The printout (Teletype 43) showed the accumulated time on each of the 64 photocells for the predetermined time period, the number of phoAbbreviations: IBMX, 3-isobutyl-1-methylxanthine; PIA, N6-(phenylisopropyl)adenosine; CHA, N6-cyclohexyladenosine.
The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 (19) but much less consistently than do amphetamines. Because preliminary open-field studies failed to show consistent locomotor stimulation with caffeine, we utilized a photoelectric activity meter with 64 sensors. Drugs such as caffeine and theophylline enhanced locomotor activity up to 4-fold compared to saline controls ( Fig. 1; Table 1 ). Caffeine and 1,7-dimethylxanthine reduced locomotor activity at lower doses (5 and 10 ,umol/kg) but stimulated. activity at 30 and 100 ,umol/kg. By contrast, no locomotor depression occurred with any dose of theophylline, 7-(f3-chloroethyl)theophylline, or 7-(,f3hydroxyethyl)theophylline.
Isocaffeine and 3-isobutyl-1-methylxanthine (IBMX) moderately depressed activity at all doses. Theobromine, 8-chlorotheophylline, and 1,9-dimethylxanthine had negligible influence on locomotor activity at all doses.
Brain levels of the alkylxanthines were assessed 30 min after a 100-,Amol/kg dose ( It has been suggested that stimulant effects of methylxanthines might be attributable to blockade of benzodiazepine receptors (21) . However, the behaviorally potent methylxanthines are about 100 times more potent at adenosine than benzodiazepine receptors and no correlation exists between behavioral potencies and effects at benzodiazepine receptors.
Influences, of L-PIA on Mouse Locomotor Activity and Interactions with Methylxanthines. Although potencies of xanthines as stimulants largely correlate with their potencies in competing for adenosine receptors, there is one notable exception. IBMX was as potent as caffeine at adenosine receptors yet failed to stimulate activity and, in fact, elicited locomotor depression. Unlike the other xanthines, IBMX is a potent phosphodiesterase inhibitor (22) , and phosphodiesterase inhibitors are usually central depressants (4) . Another difficulty in analyzing behavioral effects of xanthines is the biphasic action of agents such as caffeine and 1,7-dimethylxanthine, which reduced and stimulated behavioral activity at low and high doses, respectively. Theophylline failed to display behavioral depression at any dose examined. Differential stimulant and depressant potencies of various methylxanthines might obscure their intrinsic stimulant potencies.
To evaluate behavioral actions ofthe methylxanthines on systems specifically regulated by adenosine, we explored effects of PIA. In an earlier study, PIA elicited behavioral depression in rats (23) . We examined in detail influences of both L and D-PIA (Fig. 2) . CHA and L-PIA both were very potent in eliciting locomotor depression. The fact that L-PIA is more potent than D-PIA suggests that these effects involve adenosine Al-receptors, which display marked stereospecificity for isomers of PIA, rather than A2-receptors, at which L-and D-PIA have nearly equal potencies (13, 24) . At doses as little as 0.1 ,umol/kg, CHA or L-PIA markedly reduced locomotor activity of mice, and significant depression was detected at 0.05 ,umol/kg. These doses, around 20 /ig/kg, indicate that N6-substituted adenosines rank A flow rate of 1 ml/min gave the following retention times (min) for the 10 xanthines: 1, 6.4; 2, 5.5; 3, 11.2; 4, 7.6; 5, 9.0; 6, 13.0; 7, 7.1; 8, 10.2; 9, 4.5; 10, 7.6. The injection volume was 20 ,ul. The ultraviolet detector was set at 273 nm, and integrated peak heights were compared to those of standard solutions of methylxanthines. All values are means ± SEM; the number of mouse brains is shown in parentheses. All data are corrected for recoveries ofstandards from controlbrains. Recovery of 1,9-dimethylxanthine was less than 5% and levels ofthis xanthine could not be determined but appeared to be less than 10 ,uM. Recoveries for the other xanthines were: 1, 90%; 2, 55%; 3, 56%; 4, 100%; 5, 90%; 6, 47%; 7, 70%; 8, 33%; 10, 32%.
among the most potent psychoactive drugs, comparable to LSD and the very potent butyrophenone neuroleptic spiperone (25 ensure that L-PIA depression is centrally mediated, we showed that 8-(p-sulfophenyl)theophylline (60 mg/kg), which is as potent as theophylline at adenosine receptors (13) but is polar and not likely to enter the brain, failed to reverse L-PIA behavioral depression.
To explore possible interactions between L-PIA and methylxanthines, we administered these substances alone or in combination at various doses (Fig. 3) . At 5 and 10 Amol/kg, caffeine depressed motor activity; at 30 and 100 ,umol/kg it was a stimulant. Combining a "depressant" dose of caffeine (10 tumoVkg) with L-PIA markedly enhanced locomotor activity. Theophylline did not depress activity at any dose examined. The combination oftheophylline (10 ,u mol/kg) and L-PIA produced considerably greater enhancement of locomotor activity than occurred with the same dose of theophylline alone. jimol/kg, IBMX alone failed to enhance locomotor activity and, in fact, depressed activity at most time points. L-PIA (0.2 ,umol/ kg) also depressed activity. Strikingly, the combination ofIBMX DISCUSSION The present study strongly suggests that the behavioral stimulant effects of methylxanthines involve blockade of adenosine receptors. Potencies of methylxanthines in competing at adenosine receptor binding sites correlate with locomotor stimulation. The failure ofthe potent adenosine receptor blocker IBMX to stimulate locomotor activity directly may reflect a "contaminating" behavioral depressant effect, perhaps related to phosphodiesterase inhibition. The conversion, by low IBMX doses, of L-PIA-induced depression into a pronounced behavioral activation suggests an intrinsic stimulant activity of IBMX. Although certain of the behaviorally inactive methylxanthines display reduced brain penetration, variations of bioavailability do not account for differences in behavioral potency, and brain levels of most methylxanthines are sufficient to occupy adenosine receptors.
There appear to exist at least two distinct adenosine recep- 
